Abstract
Whether TP53, BCL-2 and BAX expressions add independent prognostic information in patients with Ta/T1bladder urothelial carcinoma remains unclear. TP53 overexpression correlated with high tumor grade ( p = 0.004), WHO grading categories (0.045), BAX expression ( p = 0.043) and pathologic stage ( p = 0.05). BCL-2 immunostaining was inverse associated with tumor grade ( p = 0.008). Lack of BAX expression was related to reduced patient’s survival ( p = 0.028). Mortality was higher in patients with BCL-2+/TP53+ ( p = 0.023) or TP53+/BAX− ( p = 0.027) phenotype. BAX and pathologic stage were independent predictors of progression-free and overall survival, respectively. Therefore, BAX expression might be relevant in patient’s prognosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
